MONOVISC for Ankle Joint Pain Relief Due to Osteoarthritis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

February 26, 2021

Study Completion Date

March 30, 2021

Conditions

Osteoarthritis Ankle

Interventions

DEVICE

Monovisc

A chemically cross-linked sodium hyaluronate supplied as a 4 mL unit dose in a 5 mL glass syringe.

Trial Locations (4)

Krajská zdravotní, a.s., Ústí nad Labem

Nzoz Medi-Spatz, Gliwice

SPORTO, Lodz

Przychodnia Rodzinna na Sadowej, Torun